EMDB Search Engine documentation
Search System
You can use the search bar near the top of all EMDB pages to search across any data deposited at EMDB and also EMPIAR.
The EMDB search engine was built using the Apache Solr server, therefore you can check the Solr query parser tutorial to find further information about how to use this engine.
Available Search Fields
You can browse and search the full list of EMDB query fields.
Query Syntax
The EMDB search engine uses the Lucene Query Syntax (more info). The types of searches that can be performed are demonstrated in examples in the following sections, note each search query can be clicked to perform that query in the live search system.
# Free text terms
Most of the text fields are broken up into single words before indexing. This procedure allows you to perform searches based on single terms or phrases (using double quotes).
The search below returns all the entries that contain the word "zika" anywhere:
The search below returns all the entries that contain the phrase "monoclonal antibody" anywhere:
# Boolean operators
More complex queries can be created by combining multiple terms and boolean operators.
| Boolean operator | Description | Example |
|---|---|---|
| AND | Both terms are required. | spliceosome AND human |
| OR | One of the terms is required. | spliceosome OR ribonucleoprotein |
| NOT | The following term must not be present. | NOT Relion |
The search terms can be grouped to form sub-queries and parentheses are used to define the order of the sub-queries. The query below returns all entries that contain the words spliceosome or ribonucleoprotein, but do not contain the word human.
"(spliceosome OR ribonucleoprotein) AND NOT human"
# Numerical Range Search
The search egnine allows the user to find entries that fall within a given range. The upper and lower bounds must be provided in the following format: "[X TO Y]". The example below finds all entries with a resolution value between 1Å and 3Å.
You can also use curly brackets to set exclusive range intervals. In the example below we are retrieving all entries with resolution value between 1Å and 3Å, but excluding entries with exactly 3Å resolution.
Range queries are not restricted to numeric fields, it is possible to search over date and text ranges. You can find the Solr documentation about date formats here. The example below returns all entries that contain samples starting with the letter "X", "Y" or "Z".
An asterisk ("*") can be used as to match any values. It can be included in a range query to define an infinite interval. The example below finds all entries with resolution value greater than or equal to 20Å.
Another use of the asterisk is to match every entry that has a value for that field. The example below list all entries that contain half-maps:
# Search by specific fields
Searching by specific fields allows the user to obtain more confident results. All you need to do is specify the field followed by a colon (":") and the term that you are searching for within the field. All the query syntax previously described is also available for specific-field searches. The full list of fields and their description can be found here.
An example to find all the human spliceosomes or ribonucleoproteins, using the sample name and the human taxonomy ID: 9606:
(sample_name:ribonucleoprotein OR sample_name:spliceosome) AND natural_source_ncbi_code:9606
# Fuzzy Search
The EMDB search engine allows the user to search by similar terms using the Damerau-Levenshtein Distance (basically, the number of edit operations necessary to transform one string in another). To perform a fuzzy search, you need to add the tilde symbol ("~") after the query term followed by the maximum distance. The example below will match any sample term that is at most one text edit from the word DNA. In other words, it will return all entries containing samples of DNA or RNA.
Quick links
Recent Entries
(Show all)Structural Insights into HIV-1 Vif-Mediated Ubiquitination and Degradation of APOBEC3H
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 13
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 12
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of PARP2, Class 2
Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (intermediate opening)
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1, Focused map
Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (minimal opening)
Human mitochondrial ClpP in complex with OICR-18704 in the heptameric state
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2, Focused map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 1, Focus map
Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (maximal opening)
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3, Focused map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7, Focus map
Nucleosome with an SSD at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 7, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Talazoparib, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9, Focus
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 14, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 14, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 2, focus map
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1, consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Olaparib, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 14
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1, focus map
Focused map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation
Cryo-EM structure of CRBN bound to 2-[5-chloro-1-(4-piperidyl)indol-4-yl]-2,5-diazaspiro[3.4]octan-6-one in the open conformation
Disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation
Disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation
Cryo-EM structure of CRBN bound to 1-[1-(4-piperidyl)indol-4-yl]hexahydropyrimidine-2,4-dione in the open conformation
Raw map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation
Raw map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation
Cryo-EM structure of CRBN bound to 1-[1-(4-piperidyl)indol-4-yl]hexahydropyrimidine-2,4-dione in the closed conformation
Focused map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation
Cryo-EM structure of monomeric bovine heart cytochrome c oxidase in amphipol A8-35
Cryo-EM structure of homotypic CENP-A nucleosome isolated from human cells
Structure of Human Aspartate--tRNA ligase 3-154 with linker and FC : ATYR0101
Cryo-EM structure of heterotypic CENP-A/H3 nucleosome isolated from human cells
A composite map of the mitochondrial ATP synthase monomer from Acanthamoeba castellanii
CryoEM structure of respiratory complex III intermediate from Acanthamoeba castellanii
Mitochondrial MDH and OSCP in the peripheral stalk of ATP synthase in Acanthamoeba castellanii
Membrane region of Acanthamoeba castellanii mitochondrial ATP synthase dimer
Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 1, Myb domain focused)
Cryo-EM structure of STITCHR (R2Tg and Cas9 nickase) bound to guide RNA, template RNA, and target DNA in the target-primed reverse transcription initiation state
Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 2)
Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 3)
A Cryo-EM Map with a Continuous Density of Sld3-CTD Binding on Mcm4-NTD-A and Mcm6-NTD-A
A Local Refined Structure for Sld7 in Complex with Dbf4-bound Mcm6
Cdc45, Sld3 and Sld7 in Complex with DDK-bound MCM Double Hexamer
A Cryo-EM map for Sld3-Sld7 on Cdc45 and DDK-bound MCM Double Hexamer with a Highly Dynamic Sld3N and Sld7N
Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 1)
CryoEM structure of DDB1-VprBP complex in "ARM-down" conformation
Immune complex comprising the HRSV preF trimer (SC-DM) and the monoclonal antibody Lor69 - Obtained by cryo-EM
Plasmodium falciparum 17-PF subpellicular microtubule associated with human hemoglobin (local refined map)
Plasmodium falciparum 17-PF subpellicular microtubule associated with human hemoglobin
Trans-1-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map
Trans-2-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map
Trans-2-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map
cis-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map
Cis-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map
Trans-1-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 1
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 2
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 3
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 4
cAMP-bound SthK monomer from symmetry expanded particles - POPE class 2
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 8
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 6
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 7
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 5
cAMP-bound SthK monomer from symmetry expanded particles - POPE class 1
Cryo-EM structure of the flagellar filament in Vibrio parahaemolyticus VP288
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), bound to diynyl arylamine (DA, aka RO-09-3143)
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-7), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-4), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 2 (pre-translocation) after 5 min reaction
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 3 (post-translocation) after 5 min reaction
Candida albicans Chitin synthase 1 (CaChs1) bound to UDP-GlcNAc and diynyl arylamine (DA, aka RO-09-3143)
Human CI-M6PR/IGF2R (cation-independent mannose-6-phosphate receptor) cryo-EM structure low pH conformation
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-3), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1) in the apo state
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-5), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-6), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-2), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 1 (post UDP hydrolysis) after 5 min reaction
Drosophila MSLHAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state overall refinement
MSL HAT nucleosome complex active H4K16Ac state Overall refinement
Drosophila MSL HAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state focused refinement
Drosophila MSL HAT nucleosome complex H4K16ac post-catalytic state
Cryo-EM map of mouse PADI6-UHRF1-UBE2D2 complex (state 2), featuring a tetrameric assembly of PADI6
Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the inverse agonist cmpd54-4, local
Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the inverse agonist cmpd54-4
Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the agonist dexamethasone phosphate (DEX-P),local
Cryo-EM structure of the MRGPRX4-miniGsq complex in the apo state
Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the agonist dexamethasone phosphate (DEX-P)
Cryo-EM structure of the MRGPRX4-miniGsq complex in the apo state, local
Drosophila MSL HAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state
Cryo-EM structure of human TMEM45A with a bound 2-Hydroxypalmitate
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4, Focus map
SARS-CoV-2 Omicron JD.1.1 spike trimer (S-6P) in complex with 3 R102-9 Fabs and 3 C092 Fabs, focused refinement of RBD and Fab region
SARS-CoV-2 Omicron JD.1.1 spike trimer (S-6P) in complex with 3 R102-9 Fabs and 3 C092 Fabs (3 RBD up)
Human condensin II bound to ADP-BeF3 in autoinhibited conformation
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
In-situ structure of the 80S yeast ribosome frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 6, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 6, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 7
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 8
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Olaparib, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 10
Nucleosome with an SSb at SHL +5.3 in complex with the WGR domain of PARP2, Class 2, consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8
